IDEXX Laboratories’ Q3 2026 Earnings: What to Expect

Based in Westbrook, Maine, IDEXX Laboratories, Inc. (IDXX) is a global healthcare company specializing in diagnostic products and software for veterinary practices. It provides testing solutions for pets, livestock, poultry, dairy, and horses, alongside water quality testing and diagnostic systems for human medicine. The company has a market capitalization of $41 billion.

IDXX is scheduled to report its Q3 earnings on Monday, November 2, 2026, before the market opens. Ahead of the release, analysts expect diluted EPS of $3.70, up 8.8% from $3.40 in the year-ago quarter. IDXX has also exceeded Wall Street’s EPS estimates in each of the past four quarters, highlighting its consistent earnings performance.

For fiscal 2026, analysts expect IDXX to report EPS of $14.80, up 13.2% from $13.08 in fiscal 2025. EPS is projected to increase by another 12.2% to $16.61 in fiscal 2027.

IDXX shares have surged 16.9% over the past 52 weeks, slightly outperforming the S&P 500 Index ($SPX), which rose 16.2%, but trailing the State Street Health Care Select Sector SPDR ETF (XLV), which gained 22.2% over the same period.

On September 16, IDEXX Laboratories announced its acquisition of CoVetAI, strengthening its veterinary software and AI capabilities. The deal could support long-term growth by improving clinical workflow efficiency, increasing diagnostic utilization, and helping veterinary practices make better clinical decisions and serve more patients. Following the announcement, IDEXX shares moved marginally up. 

Analysts remain somewhat bullish on IDXX, with the stock carrying a consensus “Moderate Buy” rating. Of the 15 analysts covering the stock, eight recommend a “Strong Buy,” one suggests a “Moderate Buy,” and six rate it a “Hold.” The average analyst price target of $717.92 represents a 35.7% premium to the current share price.

On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.